SALE: For a limited time only we are offering Patent Investor+ for $249/mo. Learn More
Mar 7, 2017
1 min read
AMP Buys Shares in Paratek Pharmaceuticals (PRTK) in Hypothetical Fund
Last week on February 28, AMP bought a position in Paratek Pharmaceuticals (PRTK) by purchasing 1,672 shares at a price of $14.95/share. The transaction totaled $25,000 with 2.4% of the total fund now allocated to that position.